CN Bio appoints Neil Rumbelow as Director of Product Development

CN Bio appoints Neil Rumbelow as Director of Product Development.

Another Outbreak of TB Linked to Contaminated Bone Grafts

Contaminated bone allograft material from a single manufacturer led to five diagnosed cases of tuberculosis (TB) and two deaths so far, according to CDC data.

January 5, 2024

GAO offers 11 new policies to improve regenerative medicine development in new report

Companies that make regenerative medicines like CAR-T therapies, gene-edited stem cells and eye implants face a number of challenges that limit the development and use

July 15, 2023

Psyence Biomed Announces $2.0 Million Private Placement | Psychedelic Invest

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company“) today announced that it has entered into definitive agreements for the

December 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.